GSK.L
GSK plc
LSE · GBP · Stock
£18.55
+0.23 (+1.26%)
past month
Closed- Market cap
- £74.33B
- P/E
- 17.34
- Yield
- 3.67%
- Volume
- 13.5M
- 52 weeks
- £16.90 – £22.82
About
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK plc (GSK.L) is a healthcare company listed on the London Stock Exchange, traded in GBP. Over the past year it moved between £16.90 and £22.82, and it pays a dividend every quarter.
- Healthcare
- Drug Manufacturers - General
- London, United Kingdom
- 66.8K employees
- Led by Julie Belita Brown A.C.A.
Coming up
Ex-dividend
£0.17 per share last time
Financials
Revenue, last 12 months
£33.54B+4.00%
Earnings
Beat the estimate
4 of 4 quarters
Q4 2025
+11.18%
Q1 2026
+4.89%
Q2 2026
+7.09%
Q3 2026
+7.32%
Earnings per share, last 12 months £1.07
Analysts
21 analysts say
Hold
12-month target£2,150.05+11,490.56%
Dividends
Yield · per share, yearly
3.67%£0.68
Split 4-for-5 on Jul 19, 2022
Ownership
- Institutions
- 48.41%
- Insiders
- 1.87%
Latest insider trade Oct 9, 2026, Whyte (Victoria L)
Prices from Yahoo Finance, may be delayed